secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2022-07-29T23:59:59+00:00
Accession:  0001193125-22-206638
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 1.02, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics enters $60M CIBC term loan facility, repays $35M OrbiMed debt
-------------------------------------------------------------------------

- New $60M senior secured term loan borrowed in full on July 25, 2022, maturing in 5 years.
- Proceeds repaid $35M outstanding under OrbiMed credit agreement; balance for general corporate purposes.
- Interest at SOFR (floor 1.5%) + 2.00% or ABR + 1.00%, at company's option.
- Financial covenants require minimum liquidity (greater of $10M or trailing 4-month EBITDA burn) and minimum total net revenue (75% of plan).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312522206638/0001193125-22-206638-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312522206638/d361583d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-206638

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer